유방용 코일 시장 규모, 점유율 및 동향 분석 보고서 : 설계 유형별, 전기장 강도별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Breast Coil Market Summary

The global breast coil market size was valued at USD 340.5 million in 2025 and is projected to grow from USD 383.2 million in 2026 to USD 876.9 million by 2033, at a CAGR of 12.6% from 2026 to 2033. North America dominated the global market with the largest revenue share of 44.4% in 2025. This growth is due to the increasing demand for advanced breast imaging and the rising global burden of breast cancer.

Healthcare providers are focusing more on early and accurate diagnosis, which has increased the use of magnetic resonance imaging (MRI) systems equipped with specialized breast coils. Breast coils help improve image quality and diagnostic precision, allowing radiologists to detect abnormalities more effectively. As awareness regarding preventive healthcare and routine breast screening continues to grow, the demand for breast MRI procedures is also increasing across hospitals and diagnostic centers.

In addition, technological advancements in MRI systems are another major factor supporting market growth. Manufacturers are developing high-channel, patient-friendly breast coils that offer greater comfort, faster scanning, and enhanced imaging performance. These innovations improve workflow efficiency and support more reliable clinical outcomes, encouraging healthcare facilities to upgrade their imaging equipment. Furthermore, the integration of artificial intelligence (AI) and advanced imaging software is improving the interpretation of MRI scans, further supporting adoption.

For instance, Siemens Healthcare Private Limited offers the 16-Channel AI Breast Coil, which is designed to deliver high-quality, high-resolution 2D and 3D MR breast imaging with enhanced clarity and faster scan performance. Its 16-channel architecture with integrated preamplifiers supports advanced parallel imaging techniques, enabling iPAT acceleration factors up to 4. The coil allows simultaneous bilateral breast imaging in multiple directions and includes patient comfort features such as a positioning cushion and headrest. Its optimized design also enables accurate breast and axillary imaging, improving diagnostic efficiency.

Rising numbers of breast cancer cases have significantly increased the demand for advanced diagnostic imaging technologies, particularly magnetic resonance imaging (MRI), for early detection and accurate diagnosis. Breast coils play an important role in improving MRI image quality, enabling healthcare professionals to identify tumors and abnormalities with greater precision. Growing awareness regarding the importance of early breast cancer screening, along with government-led screening programs and improved healthcare infrastructure, is further supporting the adoption of advanced breast imaging systems.

Global Breast Coil Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast coil market report based on design type, field strength, application, end use, and region:

• Design Type Outlook (Revenue, USD Million, 2021 - 2033)
• Closed / Prone Bilateral
• Open / Interventional Unilateral
• Dedicated Breast System
• Field Strength Outlook (Revenue, USD Million, 2021 - 2033)
• 1.5T Coils
• 3.0T Coils
• Ultra-high (7T)
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Screening & Diagnosis
• MRI-Guided Biopsy
• NAC Therapy Monitoring
• Research / Clinical Trials
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostic Imaging Centers
• Breast Care Centers
• Academic / Research
• Ambulatory Surgery Center (ASCs)
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Design Type
  • 1.1.2. Field Strength
  • 1.1.3. Application
  • 1.1.4. End Use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Breast Coil Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising breast cancer cases
    • 3.2.1.2. Growing awareness of early diagnosis
    • 3.2.1.3. Advancements in MRI technology
    • 3.2.1.4. Expanding healthcare infrastructure
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. High equipment cost
    • 3.2.2.2. Lack of skilled professionals
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. AI integration in imaging
    • 3.2.3.2. Development of advanced breast coils
    • 3.2.3.3. Expansion in emerging markets
    • 3.2.3.4. Increasing screening programs
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Strong market competition
    • 3.2.4.2. Limited rural accessibility
• 3.3. Breast Coil Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Breast Coil Market: Design Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Breast Coil Market: Design Type Movement Analysis, 2025 & 2033 (USD Million)
• 4.3. Global Breast Coil Market Size & Trend Analysis, by Design Type, 2021 to 2033 (USD Million)
• 4.4. Closed / Prone Bilateral
  • 4.4.1. Closed / prone bilateral market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Open / Interventional Unilateral
  • 4.5.1. Open / interventional unilateral market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. Dedicated Breast System
  • 4.6.1. Dedicated breast system market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Breast Coil Market: Field Strength Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Breast Coil Market: Field Strength Movement Analysis, 2025 & 2033 (USD Million)
• 5.3. Global Breast Coil Market Size & Trend Analysis, by Field Strength, 2021 to 2033 (USD Million)
• 5.4. 1.5T Coils
  • 5.4.1. 1.5T coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. 3.0T Coils
  • 5.5.1. 3.0T coils market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Ultra-high (7T)
  • 5.6.1. Ultra-high (7T) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Breast Coil Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Breast Coil Market: Application Movement Analysis, 2025 & 2033 (USD Million)
• 6.3. Global Breast Coil Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
• 6.4. Screening & Diagnosis
  • 6.4.1. Screening & diagnosis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. MRI-Guided Biopsy
  • 6.5.1. MRI-Guided biopsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. NAC Therapy Monitoring
  • 6.6.1. NAC therapy monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Research / Clinical Trials
  • 6.7.1. Research / clinical trials market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Breast Coil Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Breast Coil Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
• 7.3. Global Breast Coil Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Diagnostic Imaging Centres
  • 7.5.1. Diagnostic imaging centres market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Breast Care Centres
  • 7.6.1. Breast care centres market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Academic / Research
  • 7.7.1. Academic / research market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.8. Ambulatory Surgery Center (ASCs)
  • 7.8.1. Ambulatory surgery center (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Breast Coil Market: Regional Estimates & Trend Analysis by Design Type, Field Strength, Application, and End Use

• 8.1. Regional Dashboard
• 8.2. Market Size and Trend Analysis, 2021 to 2033
• 8.3. North America
  • 8.3.1. North America breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory framework
    • 8.3.2.4. Reimbursement scenario
    • 8.3.2.5. U.S. breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory framework
    • 8.3.3.4. Reimbursement scenario
    • 8.3.3.5. Canada breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory framework
    • 8.3.4.4. Reimbursement scenario
    • 8.3.4.5. Mexico breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. UK breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. Germany breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Competitive scenario
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. France breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Competitive scenario
    • 8.4.5.3. Regulatory framework
    • 8.4.5.4. Reimbursement scenario
    • 8.4.5.5. Italy breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Competitive scenario
    • 8.4.6.3. Regulatory framework
    • 8.4.6.4. Reimbursement scenario
    • 8.4.6.5. Spain breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Competitive scenario
    • 8.4.7.3. Regulatory framework
    • 8.4.7.4. Reimbursement scenario
    • 8.4.7.5. Sweden breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Competitive scenario
    • 8.4.8.3. Regulatory framework
    • 8.4.8.4. Reimbursement scenario
    • 8.4.8.5. Denmark breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key country dynamics
    • 8.4.9.2. Competitive scenario
    • 8.4.9.3. Regulatory framework
    • 8.4.9.4. Reimbursement scenario
    • 8.4.9.5. Norway breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. China breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Japan
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. Japan breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. India breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. South Korea breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Australia breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Regulatory framework
    • 8.5.7.4. Reimbursement scenario
    • 8.5.7.5. Thailand breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Brazil breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. Argentina breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.7. Middle East and Africa
  • 8.7.1. Middle East and Africa breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. South Africa breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Saudi Arabia breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement scenario
    • 8.7.4.5. UAE breast coil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement scenario
    • 8.7.5.5. Kuwait breast coil market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Market Share Analysis, 2025
• 9.4. Company Heat Map Analysis
• 9.5. Strategy Mapping
  • 9.5.1. Expansion
  • 9.5.2. Mergers & Acquisition
  • 9.5.3. Partnerships & Collaborations
  • 9.5.4. New Technology Launches
  • 9.5.5. Research And Development
  • 9.5.6. Company Profiles
  • 9.5.7. Siemens Healthcare Private Limited
    • 9.5.7.1. Company overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Product Benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. Koninklijke Philips N.V.
    • 9.5.8.1. Company overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Product Benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. GE HealthCare
    • 9.5.9.1. Company overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Product Benchmarking
    • 9.5.9.4. Strategic initiatives
  • 9.5.10. NeoCoil
    • 9.5.10.1. Company overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Product Benchmarking
    • 9.5.10.4. Strategic initiatives
  • 9.5.11. NORAS MRI Products
    • 9.5.11.1. Company overview
    • 9.5.11.2. Financial performance
    • 9.5.11.3. Product Benchmarking
    • 9.5.11.4. Strategic initiatives
  • 9.5.12. Canon Medical Systems, USA
    • 9.5.12.1. Company overview
    • 9.5.12.2. Financial performance
    • 9.5.12.3. Product Benchmarking
    • 9.5.12.4. Strategic initiatives
  • 9.5.13. AURORA HEALTHCARE US CORP
    • 9.5.13.1. Company overview
    • 9.5.13.2. Financial performance
    • 9.5.13.3. Product Benchmarking
    • 9.5.13.4. Strategic initiatives
  • 9.5.14. FUJIFILM Corporation
    • 9.5.14.1. Company overview
    • 9.5.14.2. Financial performance
    • 9.5.14.3. Product Benchmarking
    • 9.5.14.4. Strategic initiatives
  • 9.5.15. Hologic, Inc.
    • 9.5.15.1. Company overview
    • 9.5.15.2. Financial performance
    • 9.5.15.3. Product Benchmarking
    • 9.5.15.4. Strategic initiatives
  • 9.5.16. ScanMed, LLC
    • 9.5.16.1. Company overview
    • 9.5.16.2. Financial performance
    • 9.5.16.3. Product Benchmarking
    • 9.5.16.4. Strategic initiatives